EDIT
Price
$1.56
Change
-$0.16 (-9.30%)
Updated
Mar 10 closing price
Capitalization
142.72M
50 days until earnings call
MGTX
Price
$6.09
Change
-$0.29 (-4.55%)
Updated
Mar 10 closing price
Capitalization
498.62M
One day until earnings call
Ad is loading...

EDIT vs MGTX

Header iconEDIT vs MGTX Comparison
Open Charts EDIT vs MGTXBanner chart's image
Editas Medicine
Price$1.56
Change-$0.16 (-9.30%)
Volume$3.12M
Capitalization142.72M
MeiraGTx Holdings
Price$6.09
Change-$0.29 (-4.55%)
Volume$366.4K
Capitalization498.62M
EDIT vs MGTX Comparison Chart
Loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDIT vs. MGTX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a Buy and MGTX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (EDIT: $1.55 vs. MGTX: $6.09)
Brand notoriety: EDIT and MGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 67% vs. MGTX: 116%
Market capitalization -- EDIT: $142.72M vs. MGTX: $498.62M
EDIT [@Biotechnology] is valued at $142.72M. MGTX’s [@Biotechnology] market capitalization is $498.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 1 FA rating(s) are green whileMGTX’s FA Score has 0 green FA rating(s).

  • EDIT’s FA Score: 1 green, 4 red.
  • MGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, EDIT is a better buy in the long-term than MGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 4 TA indicator(s) are bullish while MGTX’s TA Score has 3 bullish TA indicator(s).

  • EDIT’s TA Score: 4 bullish, 6 bearish.
  • MGTX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, EDIT is a better buy in the short-term than MGTX.

Price Growth

EDIT (@Biotechnology) experienced а -12.15% price change this week, while MGTX (@Biotechnology) price change was -6.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.04%. For the same industry, the average monthly price growth was -8.82%, and the average quarterly price growth was -8.10%.

Reported Earning Dates

EDIT is expected to report earnings on Apr 30, 2025.

MGTX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-0.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX($499M) has a higher market cap than EDIT($143M). EDIT YTD gains are higher at: 22.441 vs. MGTX (0.000). MGTX has higher annual earnings (EBITDA): -61.2M vs. EDIT (-222.63M). EDIT has more cash in the bank: 265M vs. MGTX (123M). EDIT has less debt than MGTX: EDIT (38.5M) vs MGTX (86.7M). EDIT has higher revenues than MGTX: EDIT (61.8M) vs MGTX (13.9M).
EDITMGTXEDIT / MGTX
Capitalization143M499M29%
EBITDA-222.63M-61.2M364%
Gain YTD22.4410.000-
P/E RatioN/AN/A-
Revenue61.8M13.9M445%
Total Cash265M123M215%
Total Debt38.5M86.7M44%
FUNDAMENTALS RATINGS
EDIT vs MGTX: Fundamental Ratings
EDIT
MGTX
OUTLOOK RATING
1..100
8571
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
59
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9596
PRICE GROWTH RATING
1..100
9291
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EDIT's Valuation (24) in the Biotechnology industry is somewhat better than the same rating for MGTX (59). This means that EDIT’s stock grew somewhat faster than MGTX’s over the last 12 months.

EDIT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MGTX (100). This means that EDIT’s stock grew similarly to MGTX’s over the last 12 months.

EDIT's SMR Rating (95) in the Biotechnology industry is in the same range as MGTX (96). This means that EDIT’s stock grew similarly to MGTX’s over the last 12 months.

MGTX's Price Growth Rating (91) in the Biotechnology industry is in the same range as EDIT (92). This means that MGTX’s stock grew similarly to EDIT’s over the last 12 months.

MGTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as EDIT (100). This means that MGTX’s stock grew similarly to EDIT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EDITMGTX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 20 days ago
77%
Bullish Trend 20 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
74%
View a ticker or compare two or three
Ad is loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSMAX11.82N/A
N/A
Hartford Small Cap Value A
GQJPX10.83N/A
N/A
GQG Partners Intl Qual Val Fd Inv
GTHIX37.26N/A
N/A
Invesco Health Care Invstor
MLPIX111.09N/A
N/A
ProFunds Mid Cap Value Inv
PCAQX78.92N/A
N/A
Principal Capital Appreciation R5

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been loosely correlated with AXON. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if EDIT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
-9.59%
AXON - EDIT
52%
Loosely correlated
-2.08%
CRSP - EDIT
49%
Loosely correlated
-4.81%
VCYT - EDIT
49%
Loosely correlated
-5.09%
ARRY - EDIT
47%
Loosely correlated
+3.74%
PRME - EDIT
47%
Loosely correlated
-13.33%
More

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with NTLA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
-4.55%
NTLA - MGTX
47%
Loosely correlated
-8.60%
ABOS - MGTX
47%
Loosely correlated
-4.00%
AURA - MGTX
47%
Loosely correlated
-2.57%
BEAM - MGTX
47%
Loosely correlated
-9.80%
RGNX - MGTX
46%
Loosely correlated
-5.21%
More